ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 114 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $3,540,000 | -49.8% | 293,766 | -11.8% | 0.07% | -48.9% |
Q2 2021 | $7,045,000 | -20.5% | 333,085 | +5.4% | 0.13% | -30.3% |
Q1 2021 | $8,862,000 | -24.3% | 315,920 | -29.9% | 0.19% | -28.5% |
Q4 2020 | $11,710,000 | -35.5% | 450,398 | -7.7% | 0.26% | -57.3% |
Q3 2020 | $18,143,000 | +13.4% | 488,099 | +56.6% | 0.62% | +6.6% |
Q2 2020 | $15,997,000 | +120.2% | 311,776 | +35.3% | 0.58% | +47.8% |
Q1 2020 | $7,266,000 | -57.3% | 230,454 | -19.2% | 0.39% | -50.1% |
Q4 2019 | $17,014,000 | +200.1% | 285,327 | +84.5% | 0.78% | +151.0% |
Q3 2019 | $5,669,000 | +13.9% | 154,628 | +42.9% | 0.31% | -11.4% |
Q4 2018 | $4,977,000 | +0.6% | 108,200 | -2.9% | 0.35% | +31.3% |
Q3 2018 | $4,945,000 | +17.5% | 111,450 | +3.8% | 0.27% | +5.9% |
Q2 2018 | $4,207,000 | +35.5% | 107,350 | -56.7% | 0.25% | +136.4% |
Q4 2016 | $3,105,000 | -9.6% | 248,030 | 0.0% | 0.11% | -4.5% |
Q3 2016 | $3,435,000 | +40.1% | 248,030 | 0.0% | 0.11% | +25.8% |
Q2 2016 | $2,451,000 | -41.5% | 248,030 | +0.2% | 0.09% | -41.4% |
Q1 2016 | $4,187,000 | -24.0% | 247,630 | 0.0% | 0.15% | -20.0% |
Q4 2015 | $5,512,000 | -22.0% | 247,630 | -17.3% | 0.19% | -13.2% |
Q3 2015 | $7,067,000 | -67.9% | 299,580 | +11.1% | 0.22% | -64.9% |
Q2 2015 | $22,041,000 | +2.3% | 269,580 | +15.8% | 0.62% | +1.1% |
Q1 2015 | $21,555,000 | – | 232,780 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital LLC | 1,637,125 | $27,684,000 | 5.54% |
BVF INC/IL | 606,801 | $10,261,000 | 2.54% |
Sarissa Capital Management LP | 633,000 | $10,704,000 | 2.36% |
Glacier Peak Capital LLC | 38,048 | $989,000 | 0.85% |
BB BIOTECH AG | 1,008,542 | $17,054,000 | 0.68% |
FT Options LLC | 31,296 | $529,000 | 0.55% |
Rhenman & Partners Asset Management AB | 150,000 | $2,537,000 | 0.50% |
Virtus ETF Advisers LLC | 11,011 | $186,000 | 0.26% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 806,105 | $13,631,000 | 0.20% |
WASATCH ADVISORS LP | 759,183 | $12,519,000 | 0.19% |